COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH ORAL BISPHOSPHONATES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN

被引：0
|
作者：
Hiligsmann, M. [1 ]
Reginster, J. Y. [1 ]
机构：
[1] Univ Liege, Liege, Belgium
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of alendronate in the treatment of postmenopausal women in the UK
    Borgström, F
    Johnell, O
    Jönsson, B
    Kanis, J
    Kong, SX
    Sen, SS
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S13 - S13
  • [42] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hansson-Hedblom, A.
    Geale, K.
    Borgstrom, F.
    Johansson, H.
    Fitzpatrick, L.
    Kanis, J. A.
    [J]. VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [43] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [44] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Johnson, Ben
    Lai, Edward Chia-Cheng
    Ou, Huang-tz
    Li, Hong
    Stollenwerk, Bjorn
    [J]. ARCHIVES OF OSTEOPOROSIS, 2021, 16 (01)
  • [45] DENOSUMAB COMPARED WITH ALENDRONATE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ALENDRONATE
    Bernad, M.
    Garces, M.
    Martin Mola, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 768 - 768
  • [46] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared With Bisphosphonates in Postmenopausal Women Previously Treated With Oral Bisphosphonates.
    Miller, P.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, R. B.
    Brown, J. P.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S271 - S271
  • [47] Cost-effectiveness of raloxifene to prevent osteoporotic fractures among postmenopausal women in Australia
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Grainger, D
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S28 - S28
  • [48] Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
    Ben Johnson
    Edward Chia-Cheng Lai
    Huang-tz Ou
    Hong Li
    Björn Stollenwerk
    [J]. Archives of Osteoporosis, 2021, 16
  • [49] COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM
    Curtis, J.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S580 - S580
  • [50] The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women
    Stevenson, M.
    Davis, S.
    Lloyd-Jones, M.
    Beverley, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (04) : 1 - +
12345